---
layout: post
title: USAN Watch - November 2010
date: '2010-11-09T06:15:00.003Z'
author: John Overington
tags:
- INNS and USANS
modified_time: '2010-12-23T09:52:14.813Z'
thumbnail: http://3.bp.blogspot.com/_SlPG9DIz_AA/TRMbwypiQUI/AAAAAAAAA9c/9HE4sEHOY1Y/s72-c/inns+and+usans.png
blogger_id: tag:blogger.com,1999:blog-2546008714740235720.post-54609954205161834
blogger_orig_url: http://chembl.blogspot.com/2010/11/usan-watch-november-2010.html
---

<div class="separator" style="clear: both; text-align: center;"><a href="http://3.bp.blogspot.com/_SlPG9DIz_AA/TRMbwypiQUI/AAAAAAAAA9c/9HE4sEHOY1Y/s1600/inns+and+usans.png" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" src="http://3.bp.blogspot.com/_SlPG9DIz_AA/TRMbwypiQUI/AAAAAAAAA9c/9HE4sEHOY1Y/s1600/inns+and+usans.png" /></a></div><div class="separator" style="clear: both; text-align: center;"><br />
</div>The November batch of USANs have recently been announced.<br />
<br />
<table border="1"><tbody>
<tr><td><b>USAN</b></td><td><b>Research code</b> </td><td><b>Drug Type</b> </td><td><b>Drug Class</b></td><td><b>Target</b> </td></tr>
<tr><td><a href="http://www.ama-assn.org/ama1/pub/upload/mm/365/adomiparin.pdf">adomiparin</a></td><td>M-118</td><td>oligosaccharide</td><td>therapeutic</td><td>Antithrombin III</td></tr>
<tr><td><a href="http://www.ama-assn.org/ama1/pub/upload/mm/365/adomiparin-sodium.pdf">adomiparin sodium</a></td><td>M-118</td><td>oligosaccharide (salt)</td><td>therapeutic</td><td>Antithrombin III</td></tr>
<tr><td><a href="http://www.ama-assn.org/ama1/pub/upload/mm/365/alvocidib-hydrochloride.pdf">alvocidib hydrochloride</a></td><td>HMR-1275, MDL-107826A, L-868275, HL-275</td><td>small molecule (salt)</td><td>therapeutic</td><td>CDK</td></tr>
<tr><td><a href="http://www.ama-assn.org/ama1/pub/upload/mm/365/cenplacel-l.pdf">cenplacel-L</a></td><td>PDA-001</td><td>cell</td><td>therapeutic</td><td></td></tr>
<tr><td><a href="http://www.ama-assn.org/ama1/pub/upload/mm/365/delamanid.pdf">delamanid</a></td><td>OPC-67683</td><td>small molecule</td><td>therapeutic</td><td>complex </td></tr>
<tr><td><a href="http://www.ama-assn.org/ama1/pub/upload/mm/365/florbenazine-f-18.pdf">florbenazine F18</a></td><td>18F-AV-133</td><td>small molecule</td><td>imaging agent</td><td>VMAT2</td></tr>
<tr><td><a href="http://www.ama-assn.org/ama1/pub/upload/mm/365/forigerimod.pdf">forigerimod</a></td><td>IPP-201101</td><td>oligopeptide</td><td>therapeutic</td><td>nucleolin</td></tr>
<tr><td><a href="http://www.ama-assn.org/ama1/pub/upload/mm/365/forigerimod-acetate.pdf">forigerimod acetate</a></td><td>CEP-33457, P-140, IPP-201101</td><td>oligopeptide (salt)</td><td>therapeutic</td><td>nucleolin</td></tr>
<tr><td><a href="http://www.ama-assn.org/ama1/pub/upload/mm/365/ibuprofen-sodium.pdf">ibuprofen sodium</a></td><td><br />
</td><td>small molecule (salt)</td><td>therapeutic</td><td>COX-1, COX-2</td></tr>
<tr><td><a href="http://www.ama-assn.org/ama1/pub/upload/mm/365/lenvatinib-mesylate.pdf">lenvatinib mesylate</a></td><td>E-7080</td><td>small molecule (salt)</td><td>therapeutic</td><td>VEGFR2, VEGFR3</td></tr>
<tr><td><a href="http://www.ama-assn.org/ama1/pub/upload/mm/365/ozoralizumab.pdf">ozoralizumab</a></td><td>ATN-103</td><td>mAb</td><td>therapeutic</td><td>TNFalpha</td></tr>
<tr><td><a href="http://www.ama-assn.org/ama1/pub/upload/mm/365/tedizolid.pdf">tedizolid</a></td><td>TR-700</td><td>small molecule</td><td>therapeutic</td><td>23S ribosome</td></tr>
<tr><td><a href="http://www.ama-assn.org/ama1/pub/upload/mm/365/tedizolid-phosphate.pdf">tedizolid phosphate</a></td><td>TR-701FA</td><td>small molecule (prodrug)</td><td>therapeutic</td><td>23S ribosome</td></tr>
</tbody><tbody> </tbody></table><br />
Tedizolid replaces the USAN Torezolid.